Marketing-authorisation holder
Gan & Lee Pharmaceuticals Europe GmbH
10 medicines in 4 countries, as authorisation holder and marketer.
Group structure
Part of
GANPharmaceutical groupOther companies in the group
Brazil1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BYSUMLOGSoluzione iniettabile in penna pre-riempita | Insulin lispro | Italy | Authorised | |
| Bysumlog | Insulin lispro | EU (EMA) | Authorised | 2026 |
| Bysumlog 100 eenheden/ml oplossing voor injectie in een voorgevulde penOplossing voor injectie | Insulin lispro | Netherlands | Authorised | 2026 |
| BYSUMLOG 100 UNIDADES/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA10,41 mg · Solución inyectable en pluma precargada | Insulin lispro | Spain | Authorised | 2026 |
| Dazparda | Insulin aspart | EU (EMA) | Authorised | 2026 |
| DAZPARDASoluzione iniettabile in penna pre-riempita | Insulin aspart | Italy | Authorised | |
| Dazparda 100 eenheden/ml oplossing voor injectie in een voorgevulde penOplossing voor injectie | Insulin aspart | Netherlands | Authorised | 2026 |
| DAZPARDA 100 UNIDADES/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA10,50 mg · Solución inyectable en pluma precargada | Insulin aspart | Spain | Authorised | 2026 |
| Ondibta | Insulin glargine | EU (EMA) | Authorised | 2026 |
| ONDIBTASoluzione iniettabile in penna pre-riempita | Insulin glargine | Italy | Authorised |